CVS Health CorpNYSE:CVS
- LAST PRICE61.2700
- TODAY'S CHANGE (%)0.3300 (0.5415%)
- Bid / Lots61.2600/ 1
- Ask / Lots61.2700/ 1
- Open / Previous Close60.7000 / 60.9400
- Day Range
- 52 Week Range
- Volume1,657,293
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CVS |
|---|---|---|
| 09:32 ET | 145535 | 60.71 |
| 09:34 ET | 27480 | 60.81 |
| 09:36 ET | 49182 | 61.1245 |
| 09:38 ET | 54579 | 61.13 |
| 09:39 ET | 52474 | 61.23 |
| 09:41 ET | 89586 | 61.255 |
| 09:43 ET | 70743 | 61.26 |
| 09:45 ET | 377184 | 61.24 |
| 09:48 ET | 65304 | 61.0925 |
| 09:50 ET | 26998 | 61.19 |
| 09:52 ET | 50618 | 61.27 |
| 09:54 ET | 23339 | 61.175 |
| 09:56 ET | 41307 | 61.06 |
| 09:57 ET | 32293 | 61.1 |
| 09:59 ET | 81227 | 61.24 |
| 10:01 ET | 87419 | 61.215 |
| 10:03 ET | 46772 | 61.29 |
| 10:06 ET | 22817 | 61.27 |
Yesterday
Jun 5, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVS Health Corporation - CVS, from 5:07PM ET on Wednesday Jun 05, 2024 by Dow Jones
5:07PM ET on Wednesday Jun 05, 2024 by Dow JonesThe Schall Law Firm Announces A Probe Into Allegations Against CVS Health Corporation (CVS) And Calls For Investor Participation, from 1:02PM ET on Wednesday Jun 05, 2024 by Dow Jones
1:02PM ET on Wednesday Jun 05, 2024 by Dow Jones
Jun 4, 2024
The Schall Law Firm Declares an Investigation into Accusations Against CVS Health Corporation and Advocates for Investor Engagement, from 2:32PM ET on Tuesday Jun 04, 2024 by Dow Jones
2:32PM ET on Tuesday Jun 04, 2024 by Dow JonesDJ Influencers Are Driving a New Category of Unionizing: Pharmacists -- WSJ, from 8:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
8:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CVS Health Corp | 74.8B | 10.8x | --- |
HCA Healthcare Inc | 89.0B | 16.7x | +15.80% |
Welltower Inc | 62.0B | 151.8x | -10.49% |
Ventas Inc | 20.3B | -273.6x | --- |
Labcorp Holdings Inc | 16.4B | 43.5x | -13.71% |
Tenet Healthcare Corp | 13.2B | 5.2x | +41.18% |
Company Information
CVS Health Corporation is a health solutions company. The Company operates in four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Its Health Care Benefits segment offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services segment provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services, including pharmacy patient care programs, diagnostic testing and vaccination administration.
Contact Information
- Headquarters
- 1 Cvs DrWOONSOCKET, RI, United States 02895-6146
- Phone
- 401-765-1500
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Roger Farah
- President, Chief Executive Officer, Director
- Karen Lynch
- Chief Financial Officer, Executive Vice President
- Thomas Cowhey
- Chief People Officer, Executive Vice President
- Laurie Havanec
- Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
- Tilak Mandadi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $74.8B |
|---|---|
Revenue (TTM) | $360.9B |
Shares Outstanding | 1.3B |
Dividend Yield | 4.34% |
Annual Dividend Rate | 2.6600 USD |
Ex-Dividend Date | 04-19-24 |
Pay Date | 05-01-24 |
Beta | 0.52 |
EPS | $5.69 |
Book Value | $59.36 |
P/E Ratio | 10.8x |
Price/Sales (TTM) | 0.2 |
Price/Cash Flow (TTM) | 6.3x |
Operating Margin | 3.48% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
